4.8 Article

COMMD1 disrupts HIF-1 alpha/beta dimerization and inhibits human tumor cell invasion

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 120, Issue 6, Pages 2119-2130

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI40583

Keywords

-

Funding

  1. NIH [R01 DK073639]
  2. University of Texas DOCS Award
  3. Dutch Cancer Society [UU2003-2825]
  4. 2nd AEGON International Scholarship in Oncology
  5. Dutch Organization for Scientific Research [40-00812-98-03106, 817.02.022]
  6. Maurits Anna de Kock Foundation
  7. Nijbakker Morra
  8. NATIONAL CANCER INSTITUTE [R01CA094172] Funding Source: NIH RePORTER
  9. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073639] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The gene encoding COMM domain-containing 1 (COMMD1) is a prototypical member of the COMMD gene family that has been shown to inhibit both NF-kappa B- and HIF-mediated gene expression. NF-kappa B and HIF are transcription factors that have been shown to play a role in promoting tumor growth, survival, and invasion. In this study, we demonstrate that COMMD1 expression is frequently suppressed in human cancer and that decreased COMMD1 expression correlates with a more invasive tumor phenotype. We found that direct repression of COMMD1 in human cell lines led to increased tumor invasion in a chick xenograft model, while increased COMMD1 expression in mouse melanoma cells led to decreased lung metastasis in a mouse model. Decreased COMMD1 expression also correlated with increased expression of genes known to promote cancer cell invasiveness, including direct targets of HIF. Mechanistically, our studies show that COMMD1 inhibits HIF-mediated gene expression by binding directly to the amino terminus of HIF-1 alpha, preventing its dimerization with HIF-1 beta and subsequent DNA binding and transcriptional activation. Altogether, our findings demonstrate a role for COMMD1 in tumor invasion and provide a detailed mechanism of how this factor regulates the HIF pathway in cancer cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available